The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Leveraging the mechanism of action (MOA) of xevinapant, an IAP inhibitor, for phase 3 dosing (RP3D) strategies in combination with radiation (RT) and chemoradiotherapy (CRT) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Yulia  Vugmeyster

Employment - EMD Serono

Abhigyan  Ravula

Employment - EMD Serono

Elisabeth  Rouits

Employment - Debiopharm Group

Roberta  Ferretti

Employment - EMD Serono

Kathrin  Glaeser

Employment - Merck KGaA

Christina  Esdar

Employment - Merck KGaA

Andreas  Schröder

Employment - Merck KGaA

Andre  Koenig

Employment - Merck KGaA

Karthik  Venkatakrishnan

Employment - EMD Serono

Kosalaram  Goteti

Employment - EMD Serono